Service agreement for the viia 7 real-time PCR
Ended Awarded Last action
- Contract number
- 75N91024F00010
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,934
Award facts
- Contract value 100% obligated
- $21,933.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute has awarded Life Technologies Corporation, doing business as Thermo Fisher Scientific, a Blanket Purchase Agreement (BPA) call for a Service Agreement for the VIIA 7 Real-Time PCR system with a ceiling value of $21,933.96. The contract, awarded on April 16, 2024, with a completion date of April 15, 2025, is structured as a firm fixed-price engagement with no set-aside designation. Performance will take place in Rockville, Maryland, where the National Cancer Institute maintains significant research operations. This service agreement supports the institute's advanced molecular diagnostics and research capabilities through maintenance and technical support for the VIIA 7 real-time polymerase chain reaction platform, a critical instrument for gene expression analysis and nucleic acid quantification in cancer research and other biomedical applications.
Life Technologies Corporation has established itself as a leading supplier of scientific instruments and technical services to federal agencies across the National Institutes of Health, Department of Defense, and other research-focused entities. The company's expertise in providing comprehensive support for real-time PCR systems and genetic analysis equipment aligns with the National Cancer Institute's mission to advance cancer research and diagnostics. This particular BPA call represents a continuation of the vendor's established relationship with the institute, leveraging existing contract vehicles to expedite procurement and ensure continuity of essential laboratory services necessary for the institute's ongoing research initiatives.
Quick answers
Who was awarded contract 75N91024F00010?
75N91024F00010 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on April 16, 2024.
How much is contract 75N91024F00010 worth?
The government has obligated $21,934 on 75N91024F00010.
Is contract 75N91024F00010 an order under another contract?
Yes. 75N91024F00010 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91024F00010 competed?
The extent of competition for 75N91024F00010 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award